- Home
- CMPS vs BRT Comparison
CMPS vs BRT Comparison
Compare CMPS & BRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- BRT
- Stock Information
- Founded
- CMPS 2020
- BRT 1972
- Country
- CMPS United Kingdom
- BRT United States
- Employees
- CMPS N/A
- BRT N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- BRT Real Estate Investment Trusts
- Sector
- CMPS Health Care
- BRT Real Estate
- Exchange
- CMPS Nasdaq
- BRT Nasdaq
- Market Cap
- CMPS 246.5M
- BRT 291.9M
- IPO Year
- CMPS 2020
- BRT N/A
- Fundamental
- Price
- CMPS $3.87
- BRT $15.25
- Analyst Decision
- CMPS Strong Buy
- BRT Strong Buy
- Analyst Count
- CMPS 6
- BRT 3
- Target Price
- CMPS $20.20
- BRT $21.83
- AVG Volume (30 Days)
- CMPS 862.1K
- BRT 39.5K
- Earning Date
- CMPS 05-08-2025
- BRT 05-20-2025
- Dividend Yield
- CMPS N/A
- BRT 6.53%
- EPS Growth
- CMPS N/A
- BRT N/A
- EPS
- CMPS N/A
- BRT N/A
- Revenue
- CMPS N/A
- BRT $98,162,000.00
- Revenue This Year
- CMPS N/A
- BRT $0.73
- Revenue Next Year
- CMPS N/A
- BRT $5.64
- P/E Ratio
- CMPS N/A
- BRT N/A
- Revenue Growth
- CMPS N/A
- BRT 1.65
- 52 Week Low
- CMPS $2.49
- BRT $14.61
- 52 Week High
- CMPS $9.63
- BRT $20.22
- Technical
- Relative Strength Index (RSI)
- CMPS 56.88
- BRT 39.99
- Support Level
- CMPS $3.62
- BRT $15.06
- Resistance Level
- CMPS $4.03
- BRT $16.27
- Average True Range (ATR)
- CMPS 0.26
- BRT 0.52
- MACD
- CMPS -0.01
- BRT 0.03
- Stochastic Oscillator
- CMPS 38.64
- BRT 13.97
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About BRT BRT Apartments Corp. (MD)
BRT Apartments Corp is a real estate investment trust company. The company is focused on the ownership, operation, and development of multi-family properties. BRT also owns and operates other real estate assets. All of the Company's assets are comprised of multi-family real estate assets generally leased to tenants on a one-year basis.